Jose Pacheco
Physician · Utah Cancer Specialists PC
Credentials: · · · ·
History
- 2026–Present
Utah Cancer Specialists PC
- 2010–2013
Internal Medicine
Research
Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2022 · 1,255 citations
Adagrasib in Non-Small-Cell Lung Cancer Harboring a KRASG12C Mutation
New England Journal of Medicine · 2022 · 871 citations
Trastuzumab Deruxtecan in HER2-Mutant Non-Small-Cell Lung Cancer
New England Journal of Medicine · 2022 · 868 citations
11 papers
9 papers
8 papers
- RD
6 papers
6 papers · 5 as a fellow
4 papers
4 papers
4 papers
Clinical trials
- 2020–2022
Temodar Plus Tyrosine Kinase Inhibitors for Progressive CNS Disease
Principal investigator · Completed · Phase 1
University of Colorado, Denver
- 2026–2028
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
Site PI · Recruiting · Phase 2
Verastem, Inc.
- 2026–2034
A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC
Site PI · Recruiting · Phase 1, Phase 2
TRIANA Biomedicines, Inc.
- 2026–2030
First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
Site PI · Recruiting · Phase 1, Phase 2
GlaxoSmithKline